Opinion leaders say Congress should also act to improve quality and safety, and ensure Medicare solvency.

Covering the uninsured should be Congress's top health care priority over the next five years, say 87 percent of health care experts polled recently. Other top priorities are improving quality and safety of care (including increased use of information technology, 69 percent) and reforms to ensure Medicare's solvency, 50 percent.

The Commonwealth Fund's Health Care Opinion Leaders survey encompasses a broad group of 1,155 health care experts from four sectors — academia, health care delivery, business/insurance, and government/labor/consumer advocacy. Nearly 320 experts responded to the survey.

Half to two-thirds of the respondents in all four sectors rank expanding access to group health insurance (such as the federal employees' health program or Medicaid/CHIP) as a priority. In contrast, fewer than one-fourth of respondents say expanding health savings accounts (22 percent) and tax credits for the uninsured to buy individual insurance (20 percent) are priorities.

Respondents also ranked pay-for-performance methods, such as rewarding efficient providers and effective disease management, and increased use of information technology as either the first or second priority for controlling health care costs and improving quality. These were ranked high by more than two-thirds of total respondents (69 percent and 67 percent, respectively).

Top priorities for Congress in the next five years

Rank

  1. Expand coverage to the uninsured
  2. Improve the quality and safety of medical care, partly by increased use of IT
  3. Institute Medicare reforms to ensure solvency
  4. Enact reforms to moderate the rising costs of medical care for the nation
  5. Reform Medicare payment to reward quality and efficiency
  6. Control rising cost of prescription drugs
  7. Address racial/ethnic disparities in care
  8. Reform malpractice compensation
  9. Simplify and standardize administrative functions
  10. Improve Medicare coverage
  11. Raise quality of nursing homes and long-term care facilities
  12. Control Medicaid costs

Source: The Commonwealth Fund

Managed Care’s Top Ten Articles of 2016

There’s a lot more going on in health care than mergers (Aetna-Humana, Anthem-Cigna) creating huge players. Hundreds of insurers operate in 50 different states. Self-insured employers, ACA public exchanges, Medicare Advantage, and Medicaid managed care plans crowd an increasingly complex market.

Major health care players are determined to make health information exchanges (HIEs) work. The push toward value-based payment alone almost guarantees that HIEs will be tweaked, poked, prodded, and overhauled until they deliver on their promise. The goal: straight talk from and among tech systems.

They bring a different mindset. They’re willing to work in teams and focus on the sort of evidence-based medicine that can guide health care’s transformation into a system based on value. One question: How well will this new generation of data-driven MDs deal with patients?

The surge of new MS treatments have been for the relapsing-remitting form of the disease. There’s hope for sufferers of a different form of MS. By homing in on CD20-positive B cells, ocrelizumab is able to knock them out and other aberrant B cells circulating in the bloodstream.

A flood of tests have insurers ramping up prior authorization and utilization review. Information overload is a problem. As doctors struggle to keep up, health plans need to get ahead of the development of the technology in order to successfully manage genetic testing appropriately.

Having the data is one thing. Knowing how to use it is another. Applying its computational power to the data, a company called RowdMap puts providers into high-, medium-, and low-value buckets compared with peers in their markets, using specific benchmarks to show why outliers differ from the norm.
Competition among manufacturers, industry consolidation, and capitalization on me-too drugs are cranking up generic and branded drug prices. This increase has compelled PBMs, health plan sponsors, and retail pharmacies to find novel ways to turn a profit, often at the expense of the consumer.
The development of recombinant DNA and other technologies has added a new dimension to care. These medications have revolutionized the treatment of rheumatoid arthritis and many of the other 80 or so autoimmune diseases. But they can be budget busters and have a tricky side effect profile.

Shelley Slade
Vogel, Slade & Goldstein

Hub programs have emerged as a profitable new line of business in the sales and distribution side of the pharmaceutical industry that has got more than its fair share of wheeling and dealing. But they spell trouble if they spark collusion, threaten patients, or waste federal dollars.

More companies are self-insuring—and it’s not just large employers that are striking out on their own. The percentage of employers who fully self-insure increased by 44% in 1999 to 63% in 2015. Self-insurance may give employers more control over benefit packages, and stop-loss protects them against uncapped liability.